SMA caregivers face complex decisions in new era of treatment
Various ethical and social factors influence care decisions for families affected by spinal muscular atrophy (SMA) in this new…
Articles by Lindsey Shapiro, PhD
Muscle composition improves for children on Spinraza: Study
Muscle-related body composition measures improved in children with spinal muscular atrophy (SMA) types 2 and 3 who were treated…
Amino acid balance could play role in SMA, study finds
The balance of amino acids capable of influencing neurological function is disrupted in patients with spinal muscular atrophy (SMA)…
Focus of NORD study: Rare disease community’s lived experiences
The National Organization for Rare Disorders (NORD) is seeking participants for its survey-based study Living Rare, which aims to…
MRC Holland’s SMA diagnostic tests win updated EU certification
Tests by MRC Holland for identifying genetic mutations associated with spinal muscular atrophy (SMA) have met new regulatory requirements…
Zolgensma into spinal canal drives SMA type 2 motor gains
Treatment with OAV101 IT, a formulation of the gene therapy Zolgensma (onasemnogene abeparvovec-xioi) that’s delivered directly into the spinal…
Swallowing problems in SMA may be declining since advent of DMTs
Swallowing function may have improved in spinal muscular atrophy (SMA) patients since disease-modifying therapies (DMT) have become available,…
Hope on the Hill event celebrates progress in SMA research, advocacy
At Cure SMA’s 13th annual Hope on the Hill event in Washington, D.C., spinal muscular atrophy (SMA) patients,…
Low bone mineral density prevalent in older children with SMA: Study
Low bone mineral density (BMD), which leaves bones weak and prone to fractures, was found to be prevalent among children…
SMA progression in types 2 and 3 varies without treatment: Study
In the absence of treatment, the long-term progression of spinal muscular atrophy (SMA) types 2 and 3 is highly…